Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 7, 2012, Pages 1240-1248

  Cipriano, Lauren E ^a   Levesque, Barrett G ^b   Zaric, Gregory S ^c   Loftus Jr , Edward V ^b   Sandborn, William J ^b,d  

^a Stanford University   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Computed tomography enterography; Crohn's disease; Inflammatory bowel disease; Linear no threshold model; Magnetic resonance enterography; Radiation; Radiation induced cancer

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; COMPUTED TOMOGRAPHY ENTEROGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAGNETIC RESONANCE ENTEROGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RISK REDUCTION; STATISTICAL MODEL; STOMACH CANCER; SURVIVAL;

ADULT; COST-BENEFIT ANALYSIS; CROHN DISEASE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, ECONOMIC; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84862168614     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21862     Document Type: Article

References (50)

1. Huprich JE, Rosen MP, Fidler JL, et al. ACR appropriateness criteria on Crohn's disease. J Am Coll Radiol. 2010;7:94-102.
2. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81:362-378. (Pubitemid 351743850)
3. Guimaraes LS, Fidler JL, Fletcher JG, et al. Assessment of appropriateness of indications for CT enterography in younger patients. Inflamm Bowel Dis. 2010;16:226-232.
4. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. In: Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation BoRER, Division on Earth and Life Studies, ed. Washington, DC: National Research Council of the National Academies; 2006.
5. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A. 2003;100:13761-13766. (Pubitemid 37499140)
6. Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363:345-351. (Pubitemid 38169539)
7. Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern? Gastroenterology. 2005;129:328-337. (Pubitemid 41002065)
8. Berrington de Gonzalez A, Kim KP, Samet JM. Radiation-induced cancer risk from annual computed tomography for patients with cystic fibrosis. Am J Respir Crit Care Med. 2007;176:970-973. (Pubitemid 350127839)
9. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med. 2006;173:199-203. (Pubitemid 43187892)
10. Berrington de Gonzalez A, Kim KP, Berg CD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen. 2008;15:153-158.
11. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and Effects of Ionizing Radiation, Vol. 1. New York: United Nations; 2000.
12. National Council on Radiation Protection and Measurements (NCRP). Report No. 36. Evaluation of the Linear-Non-Threshold Dose- Response Model for Ionizing Radiation. Bethesda, MD: National Council on Radiation Protection and Measurements; 2001.
13. International Commission on Radiological Protection (ICRP). Publication 99: Low-dose Extrapolation of Radiation-related Cancer Risk. Ann ICRP. 2005;35.
14. Tubiana M, Aurengo A, Averbeck D, et al. Dose-effect relationships and estimation of the carcinogenic effects of low doses of ionizing radiation: the joint report of the Académie des Sciences and the Académie nationale de Médecine. Int J Radiat Oncol Biol Phys. 2005;63:317-319. (Pubitemid 41317145)
15. McCollough CH, Guimaraes L, Fletcher JG. In defense of body CT. AJR Am J Roentgenol. 2009;193:28-39.
16. Tubiana M, Feinendegen LE, Yang C, et al. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology. 2009;251:13-22.
17. Averbeck D. Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation? Health Phys. 2009;97:493-504.
18. Higgins PD, Caoili E, Zimmermann M, et al. Computed tomographic enterography adds information to clinical management in small bowel Crohn's disease. Inflamm Bowel Dis. 2007;13:262-268. (Pubitemid 46465906)
19. D'Haens GR, Fedorak R, Lemann M, et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis. 2009;15:1599-1604.
20. Pariente B, Danese S, Cosnes J, et al. Development of the Crohn's disease digestive damage score (CD3S). Inflamm Bowel Dis. 2011;17:1415-1422.
21. Kroeker KI, Lam S, Birchall I, et al. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol. 2011;45:31-39.
22. Palmer L, Herfarth H, Porter CQ, et al. Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol. 2009;104:2816-2823.
23. Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008;57:1524-1529.
24. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:2015-2022.
25. Siddiki H, Fletcher JG, Hara AK, et al. Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel. Inflamm Bowel Dis. 2011;17: 778-786.
26. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284. (Pubitemid 350190758)
27. Fidler JL, Guimaraes L, Einstein DM. MR imaging of the small bowel. Radiographics. 2009;29:1811-1825.
28. Rimola J, Ordas I, Rodriguez S, et al. Colonic Crohn's disease: value of magnetic resonance colonography for detection and quantification of disease activity. Abdom Imaging. 2010;35:422-427.
29. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut. 2009;58:1113-1120.
30. Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247:64-79.
31. Schreyer AG, Hoffstetter P, Daneschnejad M, et al. Comparison of conventional abdominal CT with MR-enterography in patients with active Crohn's disease and acute abdominal pain. Acad Radiol. 2010;17:352-357.
32. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol. 2009;193:113-121.
33. Allen BC, Baker ME, Einstein DM, et al. Effect of altering automatic exposure control settings and quality reference mAs on radiation dose, image quality, and diagnostic efficacy in MDCT enterography of active inflammatory Crohn's disease. AJR Am J Roentgenol. 2010;195:89-100.
34. Kambadakone AR, Prakash P, Hahn PF, et al. Low-dose CT examinations in Crohn's disease: impact on image quality, diagnostic performance, and radiation dose. AJR Am J Roentgenol. 2010;195:78-88.
35. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
36. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630-641.
37. Yabroff KR, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007;99:14-23.
38. Yabroff KR, McNeel TS, Waldron WR, et al. Health limitations and quality of life associated with cancer and other chronic diseases by phase of care. Med Care. 2007;45:629-637.
39. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039-1046.
40. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480-1487.
41. Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med. 1998;13:716-717. (Pubitemid 28473801)
42. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending-implications for reform. N Engl J Med. 2010;362:460-465.
43. Donnelly LF, Emery KH, Brody AS, et al. Minimizing radiation dose for pediatric body applications of single-detector helical CT: strategies at a large children's hospital. AJR Am J Roentgenol. 2001;176:303-306. (Pubitemid 32105630)
44. McCollough CH, Primak AN, Braun N, et al. Strategies for reducing radiation dose in CT. Radiol Clin North Am. 2009;47:27-40.
45. Brenner DJ. Slowing the increase in the population dose resulting from CT scans. Radiat Res. 2010;174:809-815.
46. Prakash P, Kalra MK, Kambadakone AK, et al. Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest Radiol. 2010;45:202-210.
47. Leng S, Yu L, McCollough CH. Radiation dose reduction at CT enterography: how low can we go while preserving diagnostic accuracy? AJR Am J Roentgenol. 2010;195:76-77.
48. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617-1625.
49. Siegel CA, Marden SM, Persing SM, et al. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol. 2009;7:874-881.
50. Potthast S, Rieber A, Von Tirpitz C, et al. Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison. Eur Radiol. 2002;12:1416-1422. (Pubitemid 36940217)